What does this mean for you as a buyer considering a compounded GLP-1 program
Indication context: Semaglutide injection is FDA-approved under brand names Ozempic (type 2 diabetes, CV risk reduction) and Wegovy (chronic weight management, obesity or overweight with 1 weight-related comorbidity)
Germany, the UK, France, and Scandinavia are the primary European GLP-1 markets, with strong diabetes prescribing supported by national guideline recommendations and health insurance coverage
While further RCTs are essential to confirm their efficacy and safety in PsD-specific contexts, preliminary evidence underscores their promise in reshaping the treatment landscape by simultaneously targeting systemic inflammation and metabolic dysregulation
The instructions for Zepbound, Wegovy, and Saxenda all vary slightly, but these are the general injection steps for using and disposing of a medication pen: Collect all supplies you need for the injection so that you have them within reach